dapsone has been researched along with Behcet Syndrome in 19 studies
Behcet Syndrome: Rare chronic inflammatory disease involving the small blood vessels. It is of unknown etiology and characterized by mucocutaneous ulceration in the mouth and genital region and uveitis with hypopyon. The neuro-ocular form may cause blindness and death. SYNOVITIS; THROMBOPHLEBITIS; gastrointestinal ulcerations; RETINAL VASCULITIS; and OPTIC ATROPHY may occur as well.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In dapsone-treated patients, there were significant reductions in the oral and genital ulcer parameters as well as the incidence of other cutanous and systemic manifestations." | 2.70 | Dapsone in Behçet's disease: a double-blind, placebo-controlled, cross-over study. ( Abu-Raghif, AR; Najim, RA; Sharquie, KE, 2002) |
| "Patients with Behcet's disease without oral ulcers and other diagnoses such as pemphigus vulgaris, lichen planus and herpes simplex were excluded." | 1.38 | Oral aphthosis: management gaps and recent advances. ( Liang, MW; Neoh, CY, 2012) |
| "Neutrophilic eccrine hidradenitis (NEH) is a rare distinct entity that usually presents as asymptomatic erythematous papules that disappear spontaneously in 1-3 weeks." | 1.31 | Chronic pruritic neutrophilic eccrine hidradenitis in a patient with Behçet's disease. ( Lambert, J; Meuleman, L; Nijsten, TE, 2002) |
| "All patients had oral and genital aphthae, and 22 of 25 patients had cutaneous lesions consistent with Behçet's disease." | 1.29 | Behçet's disease. Report of twenty-five patients from the United States with prominent mucocutaneous involvement. ( Jorizzo, JL; Mangelsdorf, HC; White, WL, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (21.05) | 18.7374 |
| 1990's | 1 (5.26) | 18.2507 |
| 2000's | 10 (52.63) | 29.6817 |
| 2010's | 4 (21.05) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rotondo, C | 1 |
| Lopalco, G | 1 |
| Iannone, F | 1 |
| Vitale, A | 1 |
| Talarico, R | 1 |
| Galeazzi, M | 1 |
| Lapadula, G | 1 |
| Cantarini, L | 1 |
| Fatima, J | 1 |
| Shukla, V | 1 |
| Karoli, R | 1 |
| Altiner, A | 1 |
| Mandal, R | 1 |
| Liang, MW | 1 |
| Neoh, CY | 1 |
| Nijsten, TE | 1 |
| Meuleman, L | 1 |
| Lambert, J | 1 |
| Vidaller Palacín, A | 1 |
| Robert Olalla, J | 1 |
| Sanuy Jiménez, B | 1 |
| Rufi Rigau, G | 1 |
| Folch Civit, J | 1 |
| Charte González, A | 1 |
| Najim, RA | 3 |
| Sharquie, KE | 4 |
| Al-Janabi, MH | 2 |
| Yurdakul, S | 1 |
| Hamuryudan, V | 1 |
| Yazici, H | 1 |
| Joshi, A | 1 |
| Chawla, S | 1 |
| Smart, CJ | 1 |
| Moots, RJ | 1 |
| Convit, J | 1 |
| Goihman-Yahr, M | 1 |
| Rondón-Lugo, AJ | 1 |
| Mangelsdorf, HC | 1 |
| White, WL | 1 |
| Jorizzo, JL | 1 |
| Kaklamani, VG | 1 |
| Kaklamanis, PG | 1 |
| Aynacioglu, AS | 1 |
| Bozkurt, A | 1 |
| Nacak, M | 1 |
| Kortunay, S | 1 |
| Tunc, R | 1 |
| Dincel, A | 1 |
| Kayaalp, SO | 1 |
| Abu-Raghif, AR | 1 |
| Hamza, M | 1 |
| Hamzaoui, K | 1 |
| Ayed, K | 1 |
| Kursanov, IuV | 1 |
| Sheĭnkman, EV | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Randomized, Double Blinded, Placebo-controlled Trial to Assess the Preventive Effects of Cetylpyridinium Chloride on Sarcopenia[NCT02575235] | Early Phase 1 | 100 participants (Actual) | Interventional | 2015-10-01 | Completed | ||
| Randomized, Double Blinded, Placebo-controlled Trial to Assess the Preventive Effects of Cetylpyridinium Chloride on Sarcopenia: An Exploratory Pilot Study[NCT02297997] | Early Phase 1 | 65 participants (Actual) | Interventional | 2014-11-13 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 reviews available for dapsone and Behcet Syndrome
| Article | Year |
|---|---|
Mucocutaneous Involvement in Behçet's Disease: How Systemic Treatment Has Changed in the Last Decades and Future Perspectives.
Topics: Anti-Bacterial Agents; Azathioprine; Behcet Syndrome; Colchicine; Dapsone; Humans; Interferon-alpha; | 2015 |
[Behcet's disease therapy review].
Topics: Behcet Syndrome; Colchicine; Dapsone; Humans; Methotrexate; Prednisone; Thalidomide | 2002 |
Behçet syndrome.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antiviral Agents; Autoantibodies; Behcet Syndrome; Dapsone; | 2004 |
1 trial available for dapsone and Behcet Syndrome
| Article | Year |
|---|---|
Dapsone in Behçet's disease: a double-blind, placebo-controlled, cross-over study.
Topics: Administration, Oral; Adult; Anti-Inflammatory Agents, Non-Steroidal; Behcet Syndrome; Cross-Over St | 2002 |
Dapsone in Behçet's disease: a double-blind, placebo-controlled, cross-over study.
Topics: Administration, Oral; Adult; Anti-Inflammatory Agents, Non-Steroidal; Behcet Syndrome; Cross-Over St | 2002 |
Dapsone in Behçet's disease: a double-blind, placebo-controlled, cross-over study.
Topics: Administration, Oral; Adult; Anti-Inflammatory Agents, Non-Steroidal; Behcet Syndrome; Cross-Over St | 2002 |
Dapsone in Behçet's disease: a double-blind, placebo-controlled, cross-over study.
Topics: Administration, Oral; Adult; Anti-Inflammatory Agents, Non-Steroidal; Behcet Syndrome; Cross-Over St | 2002 |
15 other studies available for dapsone and Behcet Syndrome
| Article | Year |
|---|---|
Behcet's syndrome presenting as FUO.
Topics: Adolescent; Behcet Syndrome; Colchicine; Dapsone; Dexamethasone; Diagnosis, Differential; Female; Fe | 2010 |
Behçet syndrome.
Topics: Adult; Behcet Syndrome; Dapsone; Dietary Supplements; Glucocorticoids; Humans; Male; Silver Nitrate; | 2010 |
Oral aphthosis: management gaps and recent advances.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Anti-Inf | 2012 |
Chronic pruritic neutrophilic eccrine hidradenitis in a patient with Behçet's disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Behcet Syndrome; Chronic Disease; Dapsone; Female; Hidraden | 2002 |
Acetylator phenotype in Behçet's disease.
Topics: Acetylation; Adult; Arylamine N-Acetyltransferase; Behcet Syndrome; Dapsone; Female; Folic Acid Anta | 2003 |
Acetylator phenotype in Behçet's disease.
Topics: Acetylation; Adult; Age of Onset; Behcet Syndrome; Biotransformation; Dapsone; Female; HLA-B Antigen | 2003 |
Behçet's syndrome with pyoderma-gangrenosum-like lesions treated successfully with dapsone monotherapy.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Behcet Syndrome; Combined Modality Therapy; Dapso | 2004 |
Recto-vaginal fistula: a refractory complication of Behcet's disease.
Topics: Adult; Antibodies, Monoclonal; Behcet Syndrome; Dapsone; Disease Progression; Female; Humans; Inflam | 2007 |
Effectiveness of dapsone in Behcet's disease.
Topics: Behcet Syndrome; Dapsone; Humans; Recurrence; Stomatitis, Aphthous | 1984 |
Suppression of Behçet's disease with dapsone.
Topics: Adult; Behcet Syndrome; Dapsone; Humans; Male | 1984 |
Behçet's disease. Report of twenty-five patients from the United States with prominent mucocutaneous involvement.
Topics: Administration, Topical; Adolescent; Adult; Aged; Anti-Inflammatory Agents; Behcet Syndrome; Colchic | 1996 |
Treatment of Behçet's disease--an update.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Behcet Syndrome; Chl | 2001 |
N-acetyltransferase polymorphism in patients with Behçet's disease.
Topics: Acetylation; Adult; Arylamine N-Acetyltransferase; Behcet Syndrome; Dapsone; Female; Gene Frequency; | 2001 |
Treatment of Behçet's disease with dapsone.
Topics: Adult; Behcet Syndrome; Dapsone; Female; Humans; Male; Middle Aged | 1989 |
[Behcet's syndrome].
Topics: Adult; Aloe; Behcet Syndrome; Dapsone; Humans; Male; Phytotherapy; Plants, Medicinal | 1973 |